Abstract
BackgroundAnti-Th/To antibodies, detected in 2-5% Systemic Sclerosis (SSc) patients, are associated to interstitial lung disease (ILD)1 in half of the cases. However, long-term data on ILD as well as on...
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
